JP2005505566A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505566A5
JP2005505566A5 JP2003526937A JP2003526937A JP2005505566A5 JP 2005505566 A5 JP2005505566 A5 JP 2005505566A5 JP 2003526937 A JP2003526937 A JP 2003526937A JP 2003526937 A JP2003526937 A JP 2003526937A JP 2005505566 A5 JP2005505566 A5 JP 2005505566A5
Authority
JP
Japan
Prior art keywords
steroid compound
compound according
hydrogen
therapy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003526937A
Other languages
English (en)
Japanese (ja)
Other versions
JP4471653B2 (ja
JP2005505566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/010041 external-priority patent/WO2003022864A1/en
Publication of JP2005505566A publication Critical patent/JP2005505566A/ja
Publication of JP2005505566A5 publication Critical patent/JP2005505566A5/ja
Application granted granted Critical
Publication of JP4471653B2 publication Critical patent/JP4471653B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003526937A 2001-09-12 2002-09-06 ホルモン作用を有する17α−ヒドロキシ−14β−ステロイド Expired - Fee Related JP4471653B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (3)

Publication Number Publication Date
JP2005505566A JP2005505566A (ja) 2005-02-24
JP2005505566A5 true JP2005505566A5 (enExample) 2006-01-05
JP4471653B2 JP4471653B2 (ja) 2010-06-02

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526937A Expired - Fee Related JP4471653B2 (ja) 2001-09-12 2002-09-06 ホルモン作用を有する17α−ヒドロキシ−14β−ステロイド

Country Status (28)

Country Link
US (1) US7169769B2 (enExample)
EP (1) EP1427748B1 (enExample)
JP (1) JP4471653B2 (enExample)
KR (1) KR100940054B1 (enExample)
CN (1) CN1257913C (enExample)
AR (1) AR036462A1 (enExample)
AT (1) ATE395352T1 (enExample)
AU (1) AU2002339536B2 (enExample)
BR (1) BR0212409A (enExample)
CA (1) CA2505575C (enExample)
CY (1) CY1108152T1 (enExample)
DE (1) DE60226623D1 (enExample)
DK (1) DK1427748T3 (enExample)
EC (1) ECSP045012A (enExample)
ES (1) ES2305306T3 (enExample)
HR (1) HRP20040193A2 (enExample)
HU (1) HUP0402139A3 (enExample)
IL (2) IL160451A0 (enExample)
IS (1) IS2555B (enExample)
MX (1) MXPA04002418A (enExample)
NO (1) NO326624B1 (enExample)
NZ (1) NZ531487A (enExample)
PL (1) PL207493B1 (enExample)
PT (1) PT1427748E (enExample)
RU (1) RU2294332C2 (enExample)
TW (1) TWI221154B (enExample)
WO (1) WO2003022864A1 (enExample)
ZA (1) ZA200401992B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Similar Documents

Publication Publication Date Title
JP2010510210A5 (enExample)
JP2011518845A5 (enExample)
JP2010507685A5 (enExample)
CA2577497A1 (en) 15.beta.-substituted steroids having selective estrogenic activity
CN1905885A (zh) 包含雌激素和孕激素的延长应用组合
CA2467222A1 (en) Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
CN107250149A (zh) 氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
JP2005533807A5 (enExample)
GEP20105066B (en) Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
RU2010100334A (ru) ПРОИЗВОДНОЕ 17β-ЦИАНО-18А-ГОМО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ ПРОИЗВОДНОЕ
RU2001101492A (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНДРОСТ-5-EH-3-β, 17β-ДИОЛ, И ЕГО ИСПОЛЬЗОВАНИЕ
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
CN1172949C (zh) 睾酮衍生物
JP2003512474A5 (enExample)
CA2431645A1 (en) Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy
PT1820494E (pt) Microesferas de estradiol e de colesterol
JP2009512658A5 (enExample)
JP2006507311A5 (enExample)
RU2001101892A (ru) Производное тестостерона
RU2002117440A (ru) Новые андрогены
JP2003515543A5 (enExample)
JP2003520208A5 (enExample)
JP2002540119A5 (enExample)
RU2010100331A (ru) ПРОИЗВОДНОЕ 17β-ЦИАНО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ УКАЗАННОЕ ПРОИЗВОДНОЕ
JP2002541153A5 (enExample)